USANA Form 4: 1,057 shares acquired; 2,115 RSUs remain
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
USANA Health Sciences (USNA) reported a director’s acquisition of 1,057 shares of common stock on 10/23/2025, coded “M” for settlement of restricted stock units.
After the transaction, the reporting person beneficially owns 1,057 shares directly and 2,115 restricted stock units. The RSUs vest 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
1,057 shares exercised/converted
Mixed
2 txns
Insider
FULLER GILBERT A
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 1,057 | $0.00 | -- |
| Exercise | Common Stock | 1,057 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Units — 2,115 shares (Direct);
Common Stock — 1,057 shares (Direct)
Footnotes (1)
- Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Restricted Stock Units vest 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.
FAQ
What did USNA (USNA) disclose in this Form 4?
A director acquired 1,057 shares of common stock on 10/23/2025 under transaction code M, reflecting settlement of restricted stock units.
How many restricted stock units (RSUs) remain after this transaction for USNA?
The reporting person holds 2,115 restricted stock units after the reported transaction.
What is the vesting schedule for the USNA restricted stock units?
The RSUs vest 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.
What does transaction code M indicate in this USNA Form 4?
Code M indicates the settlement of a derivative security; here, 1,057 RSUs converted into 1,057 shares of common stock at $0 for the derivative security.